Search Results - "Mendelsohn, J"

Refine Results
  1. 1

    Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions by Schaefer, G. Bradley, Mendelsohn, Nancy J.

    Published in Genetics in medicine (01-05-2013)
    “…The autism spectrum disorders are a collective of conditions that have in common impaired socialization and communication in association with stereotypic…”
    Get full text
    Journal Article
  2. 2

    The epidermal growth factor receptor as a target for cancer therapy by Mendelsohn, J

    Published in Endocrine-related cancer (01-03-2001)
    “…Epidermal growth factor (EGF) receptors are expressed at high levels in about one third of epithelial cancers, and autocrine activation of EGF receptors…”
    Get full text
    Journal Article
  3. 3

    Epidermal Growth Factor Receptor Targeting in Cancer by Mendelsohn, John, Baselga, Jose

    Published in Seminars in oncology (01-08-2006)
    “…The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase of the ErbB family that is abnormally activated in many epithelial tumors. Several…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol by Meric-Bernstam, F., Brusco, L., Daniels, M., Wathoo, C., Bailey, A.M., Strong, L., Shaw, K., Lu, K., Qi, Y., Zhao, H., Lara-Guerra, H., Litton, J., Arun, B., Eterovic, A.K., Aytac, U., Routbort, M., Subbiah, V., Janku, F., Davies, M.A., Kopetz, S., Mendelsohn, J., Mills, G.B., Chen, K.

    Published in Annals of oncology (01-05-2016)
    “…Next-generation sequencing in cancer research may reveal germline variants of clinical significance. We report patient preferences for return of results and…”
    Get full text
    Journal Article
  7. 7

    Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial by Rodon, J., Soria, J.C., Berger, R., Batist, G., Tsimberidou, A., Bresson, C., Lee, J.J., Rubin, E., Onn, A., Schilsky, R.L., Miller, W.H., Eggermont, A.M., Mendelsohn, J., Lazar, V., Kurzrock, R.

    Published in Annals of oncology (01-08-2015)
    “…Advances in ‘omics’ technology and targeted therapeutic molecules are together driving the incorporation of molecular-based diagnostics into the care of…”
    Get full text
    Journal Article
  8. 8

    Hunting Down the Chimera of Multiple Disciplinarity in Conservation Science by POOLEY, SIMON P, MENDELSOHN, J. ANDREW, MILNER‐GULLAND, E. J

    Published in Conservation biology (01-02-2014)
    “…The consensus is that both ecological and social factors are essential dimensions of conservation research and practice. However, much of the literature on…”
    Get full text
    Journal Article
  9. 9

    Genetics evaluation for the etiologic diagnosis of autism spectrum disorders by Schaefer, G. Bradley, Mendelsohn, Nancy J.

    Published in Genetics in medicine (01-01-2008)
    “…Over the past decade, the reported incidence of autism spectrum disorders has continued to increase. Coincident with this, the number of referrals to clinical…”
    Get full text
    Journal Article
  10. 10

    Elimination of Antibodies to Recombinant Enzyme in Pompe's Disease by Kishnani, Priya S, Rosenberg, Amy S, Mendelsohn, Nancy J, Messinger, Yoav H

    Published in The New England journal of medicine (08-01-2009)
    “…To the Editor: Infantile Pompe's disease is due to a deficiency of lysosomal acid alpha glucosidase (GAA). In patients in whom GAA is not produced, a status…”
    Get full text
    Journal Article
  11. 11

    Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy by Mendelsohn, J

    Published in Clinical cancer research (01-12-1997)
    “…Monoclonal antibody (mAb) 225 against the human epidermal growth factor receptor blocks activation of receptor tyrosine kinase. This retards or arrests cell…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Common Knowledge: Bodies, Evidence, and Expertise in Early Modern Germany by Mendelsohn, J. Andrew, Kinzelbach, Annemarie

    Published in Isis (01-06-2017)
    “…Over the past twenty-five years, history of science has expanded into history of knowledge. Plurality has been the main message. Commonality, by contrast, is…”
    Get full text
    Journal Article
  14. 14

    Fabrication of Microporous Thin Films from Polyelectrolyte Multilayers by Mendelsohn, J. D, Barrett, C. J, Chan, V. V, Pal, A. J, Mayes, A. M, Rubner, M. F

    Published in Langmuir (30-05-2000)
    “…A simple process has been developed to create large area, highly uniform microporous thin films. Multilayers of weak polyelectrolytes were assembled onto…”
    Get full text
    Journal Article
  15. 15

    Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS) by Ficicioglu, Can, Giugliani, Roberto, Harmatz, Paul, Mendelsohn, Nancy J., Jego, Virginie, Parini, Rossella

    “…Several cases of phenotypic variability among family members with mucopolysaccharidosis type II (MPS II) have been reported, but the data are limited. Data…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Clinical genetics evaluation in identifying the etiology of autism spectrum disorders by Schaefer, G. Bradley, Mendelsohn, Nancy J.

    Published in Genetics in medicine (01-04-2008)
    “…The autism spectrum disorders are a collection of conditions, which have, in common, impaired socialization and communication in association with stereotypic…”
    Get full text
    Journal Article
  18. 18

    Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome Survey by Mendelsohn, Nancy J., Harmatz, Paul, Bodamer, Olaf, Burton, Barbara K., Giugliani, Roberto, Jones, Simon A., Lampe, Christina, Malm, Gunilla, Steiner, Robert D., Parini, Rossella

    Published in Genetics in medicine (01-12-2010)
    “…To characterize surgical histories typical of patients with mucopolysaccharidosis type II, thereby broadening understanding of the natural history of these…”
    Get full text
    Journal Article
  19. 19

    Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin by BASELGA, J, PFISTER, D, FALCEY, J, ANDERSON, V, WAKSAL, H, MENDELSOHN, J, COOPER, M. R, COHEN, R, BURTNESS, B, BOS, M, D'ANDREA, G, SEIDMAN, A, NORTON, L, GUNNETT, K

    Published in Journal of clinical oncology (01-02-2000)
    “…The epidermal growth factor (EGF) receptor is frequently overexpressed in epithelial tumors. C225 is a human-to-murine chimeric monoclonal antibody that binds…”
    Get full text
    Journal Article
  20. 20